US.CAH · Cardinal Health

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.2393655974940607,
        "turnoverUsdM": 422.50442654329,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.CAH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 240.2742,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.5,
      "take_profit_price": 264.7398,
      "target_multiplier": 1.9,
      "technical_strength": 1.85,
      "take_profit_percent": 5.2
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.4787311949881214,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 63.2,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 59.2,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 4
  },
  "market": {
    "ma20": 241.8885,
    "ma50": 236.5984,
    "close": 251.54,
    "prevClose": 249.57,
    "avgVolume20": 1664809,
    "volumeRatio": 1.01,
    "changePercent": 0.79
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 4,
    "details": {
      "ret_5d": -0.004393429819648964,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 4,
      "vcp_bonus": 0,
      "vol_ratio": 0.9877686757190659,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.7591281665725549,
      "volat_points": 0,
      "day_range_pct": 0.017551881114410445,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 63.2,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 60,
        "contribution": 3
      },
      {
        "raw": 14,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 70,
        "contribution": 14
      },
      {
        "raw": 8.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 58.67,
        "contribution": 8.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 21,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 70,
        "contribution": 21
      },
      {
        "raw": 3,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 30,
        "contribution": 3
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 59.2,
    "details": [
      "基本面分析總分: 3/5分",
      "資金流分析總分: 14/20分",
      "市場環境分析總分: 8.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 21/30分",
      "情緒分析: 3/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3,
      "資金流": 14,
      "市場環境": 8.8,
      "情緒分析": 3,
      "技術信號": 21,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.2,
          "epsPoints": 0.4,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 422.50442654329,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 3.2,
          "obvPoints": 2.4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.CAH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 19.45
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 734.0185023500001,
                "ma50": 725.4347994000001,
                "name": "QQQ",
                "close": 712.20001,
                "points": 0.4
              },
              "spy": {
                "ma20": 770.1384979000001,
                "ma50": 767.5889950999999,
                "name": "SPY",
                "close": 765.37,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.2393655974940607,
          "atrPoints": 3,
          "cciPoints": 3.2,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 3,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.3
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 143102716,
                "url": "https://finnhub.io/api/news?id=f911496ba6f598d1bb0c52017b8a9656293eddbadd26b647dc3451d306cb93e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health earnings event puts the spotlight on sentiment Cardinal Health (CAH) heads into its planned November 5, 2026 earnings release with fresh attention after Mizuho raised expectations and the stock recently pushed through one technical entry and began testing another. Over the past year, Cardinal Health has moved from a quiet compounder to a momentum story, with a 30-day share price return of 14.05% and a 1-year total shareholder return of 62.92% that builds on an approximately 5x...",
                "category": "company",
                "datetime": 1792678447,
                "headline": "Cardinal Health (CAH) Faces An Earnings Test On A Modestly Undervalued View"
              },
              {
                "id": 143033246,
                "url": "https://finnhub.io/api/news?id=edcc7e4520556b732891fa005e7275be443421c583809d7c8ed10319818038d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) concluded the recent trading session at $257.55, signifying a +1.94% move from its prior day's close.",
                "category": "company",
                "datetime": 1792530003,
                "headline": "Cardinal Health (CAH) Laps the Stock Market: Here's Why"
              },
              {
                "id": 142849044,
                "url": "https://finnhub.io/api/news?id=fff2c2687f2485f8b522e1ef8ed6f60c96be3b7e694891cac131e7792759142f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1791895205,
                "headline": "Should Value Investors Buy Cardinal Health (CAH) Stock?"
              },
              {
                "id": 142849043,
                "url": "https://finnhub.io/api/news?id=702d29a3595bb5bd6ce2b235c02198bf102a56838370cf44c3869e37f14fb1af",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1791895205,
                "headline": "Are Medical Stocks Lagging  Cardinal Health (CAH) This Year?"
              },
              {
                "id": 142639890,
                "url": "https://finnhub.io/api/news?id=2a9b5c4bc94a40076ace620f6e0412366dce644e40182ad35f6f69dfcf6878f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.",
                "category": "company",
                "datetime": 1791234004,
                "headline": "Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know"
              },
              {
                "id": 142628856,
                "url": "https://finnhub.io/api/news?id=e3ffb0f1fe5ae01f9083e2e296562d1a5501b5f31ced31fd008934d7ec94bd70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In October 2026, Cardinal Health announced it had entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, maintaining the current scope of distribution services. This long‑dated extension reinforces the durability of Cardinal Health’s core distribution relationships, underscoring the importance of scale partnerships in its business model. We’ll now explore how the extended CVS distribution agreement through 2032 may...",
                "category": "company",
                "datetime": 1791174359,
                "headline": "How Extending CVS Distribution Through 2032 At Cardinal Health (CAH) Has Changed Its Investment Story"
              },
              {
                "id": 142499515,
                "url": "https://finnhub.io/api/news?id=ace080066fe00e3cab647d5a3270d58d32b923e43edeab3791ffd85545748769",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Even though Cardinal Health (currently trading at $220.37 per share) has gained 6.8% over the last six months, it has lagged the S&P 500’s 22.1% return during that period. This may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1790699042,
                "headline": "Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings?"
              }
            ],
            "raw_source": [
              {
                "id": 143165984,
                "url": "https://finnhub.io/api/news?id=352f3c23d139442045486e4ee957da337f5b851133d28320bdebba8e3b4e1f02",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial resilience.",
                "category": "company",
                "datetime": 1792859461,
                "headline": "Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?"
              },
              {
                "id": 143104531,
                "url": "https://finnhub.io/api/news?id=68912985e6181c5af1f0f4733f4e9cf76968ea496b24d3b31b30d00f23a6b40f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen trades at half the valuation multiple of Eli Lilly while generating stronger free cash flow, but explosive growth in obesity drugs tells a different story.",
                "category": "company",
                "datetime": 1792707302,
                "headline": "Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?"
              },
              {
                "id": 143102715,
                "url": "https://finnhub.io/api/news?id=89b45f74c18439aaaf17bcf1a893b191c20cb809a68dc7a0e5a702363bd7888e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health is preparing to report earnings in early November 2026, with forecasts pointing to higher earnings per share and revenue compared with the prior year. The upcoming results are expected to highlight how the business is converting pharmaceutical distribution and medical product demand into profit, with analyst sentiment serving mainly as a supporting signal rather than the primary focus. We will now evaluate how Cardinal Health's investment narrative holds up against these...",
                "category": "company",
                "datetime": 1792682229,
                "headline": "Should Upcoming Earnings Expectations Require Action From Cardinal Health Stock Investors?"
              },
              {
                "id": 143102716,
                "url": "https://finnhub.io/api/news?id=f911496ba6f598d1bb0c52017b8a9656293eddbadd26b647dc3451d306cb93e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health earnings event puts the spotlight on sentiment Cardinal Health (CAH) heads into its planned November 5, 2026 earnings release with fresh attention after Mizuho raised expectations and the stock recently pushed through one technical entry and began testing another. Over the past year, Cardinal Health has moved from a quiet compounder to a momentum story, with a 30-day share price return of 14.05% and a 1-year total shareholder return of 62.92% that builds on an approximately 5x...",
                "category": "company",
                "datetime": 1792678447,
                "headline": "Cardinal Health (CAH) Faces An Earnings Test On A Modestly Undervalued View"
              },
              {
                "id": 143070722,
                "url": "https://finnhub.io/api/news?id=de043044c5e77bc3cc605f967a731ee593cddf2aaaae79b91181cd129b41a8b1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Mizuho analysts raised its price target ahead of Cardinal Health's earnings. The stock is testing a buy point after topping another entry.",
                "category": "company",
                "datetime": 1792599918,
                "headline": "IBD Stock Of The Day Tests New Buy Point As Indicators Suggest More Upside"
              },
              {
                "id": 143069902,
                "url": "https://finnhub.io/api/news?id=76609308cca98e5095bb1be13805a13eb1102b42fe134ba83e8cd3213a109974",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Slatestone Wealth Partner & Chief Market Strategist Kenny Polcari talks about the biggest stories to start your trading day. Earnings are coming and causing stocks to rebound. SpaceX (SPCX) is topping its Q3 estimates, investors are watching health care earnings like Elevance Health (ELV), and what to expect with Meta's earnings coming later today. Kenny Polcari then sits down with Futurum CEO Daniel Newman to discuss Amazon (AMZN), Alphabet (GOOGL) (GOOG), and Microsoft (MSFT), the uncertainty in the tech trade, and how companies are monetizing AI.",
                "category": "company",
                "datetime": 1792591572,
                "headline": "SpaceX earnings roundup, Meta earnings preview, and tech trade fears"
              },
              {
                "id": 143053243,
                "url": "https://finnhub.io/api/news?id=dc7675857d10f53aeab8524c0476a7cf3ecd6227467f7abcbd761f00d7e2983a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- \"Disposable Specimen Container Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global disposable specimen container market is experiencing strong growth as healthcare providers, diagnostic laboratories and research organizations prioritize hygienic sample collection, specimen integrity and infection control. The market is projected to increase from $2.66 billion in 2025 to $2.89 billion in 2026, representing a compound annual",
                "category": "company",
                "datetime": 1792569900,
                "headline": "Disposable Specimen Container Market Forecast Report 2026-2030 | Capitalize on Sterile Automation and $3.97B Demand with Leading Players Thermo Fisher, Cardinal Health, SARSTEDT and Greiner Bio-One"
              },
              {
                "id": 143033085,
                "url": "https://finnhub.io/api/news?id=368b52ae880d338df7083cf25002b08ab35a8b7af679d3bdc20ca460ccb310e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen boasts stronger revenue growth, while Bristol Myers Squibb generates nearly 60% more free cash flow at half the valuation.",
                "category": "company",
                "datetime": 1792533902,
                "headline": "Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 143032156,
                "url": "https://finnhub.io/api/news?id=e49558c555026b92434592fdc119c2a0057ebb415679b659eb4a3f1b8bd61926",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie generates $17.8 billion in annual free cash flow but faces patent cliffs, while Vertex boasts a 33% net margin with concentrated cystic fibrosis exposure.",
                "category": "company",
                "datetime": 1792532102,
                "headline": "AbbVie vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 143033246,
                "url": "https://finnhub.io/api/news?id=edcc7e4520556b732891fa005e7275be443421c583809d7c8ed10319818038d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) concluded the recent trading session at $257.55, signifying a +1.94% move from its prior day's close.",
                "category": "company",
                "datetime": 1792530003,
                "headline": "Cardinal Health (CAH) Laps the Stock Market: Here's Why"
              },
              {
                "id": 143204190,
                "url": "https://finnhub.io/api/news?id=47a4ead95cce4d15c39d8e108365a1ebc83f1e1aa19e8a74a9ed53f26da58c6d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 155 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Up",
                "category": "company",
                "datetime": 1792527974,
                "headline": "Allstate Upgraded, Dell Technologies Downgraded: Updated Rankings on Top Blue-Chip Stocks"
              },
              {
                "id": 143030099,
                "url": "https://finnhub.io/api/news?id=42860f4227d9d09fbf7723d6a9cf279bfc70b2d318719ca1043a2799de1b8bf1",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2279415830/image_2279415830.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "BlackRock CII delivers a 7.25% yield using covered calls on a tech-heavy portfolio.",
                "category": "company",
                "datetime": 1792504423,
                "headline": "CII: Strong Recent Performance, But AI Exposure Could Trigger Losses"
              },
              {
                "id": 143028190,
                "url": "https://finnhub.io/api/news?id=74013e131e8a875dce40d0a99b9b94c12c9b7ff2bacdf94abfdf805d61636a3b",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Mizuho  analyst Steven Valiquette   maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.",
                "category": "company",
                "datetime": 1792483851,
                "headline": "Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280"
              },
              {
                "id": 143006891,
                "url": "https://finnhub.io/api/news?id=5e2b4ba7a25fabb6e7a5960d621a2f2fcdfc08fc6ab2f4577b3870acf62685d0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
                "category": "company",
                "datetime": 1792414135,
                "headline": "1 Profitable Stock Worth Investigating and 2 We Brush Off"
              },
              {
                "id": 142961078,
                "url": "https://finnhub.io/api/news?id=b61774a049ee249e14d75bd0960ba07c7b622a8c32eb0e8f9d7c51c43bbb3310",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "UBS  analyst Kevin Caliendo   maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $295.",
                "category": "company",
                "datetime": 1792158017,
                "headline": "UBS Maintains Buy on Cardinal Health, Raises Price Target to $295"
              },
              {
                "id": 142922285,
                "url": "https://finnhub.io/api/news?id=e55ca2d20a0f963b7d205e3befbf4d17eb09a9b24af869bcc4bfcaa8989ea739",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie, meanwhile, closed just shy of a record high, with shares ticking up 0.6% to $283.40.",
                "category": "company",
                "datetime": 1792096200,
                "headline": "Gilead and Cardinal Health Stocks Jump to Record Highs. Why Healthcare Is on a Tear."
              },
              {
                "id": 142921431,
                "url": "https://finnhub.io/api/news?id=abb5ce5c48a5a67fcbbfc9d5515d0db9a0a3c0bf15d473facce8f6a61f2b43fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.",
                "category": "company",
                "datetime": 1792089120,
                "headline": "3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge"
              },
              {
                "id": 142919291,
                "url": "https://finnhub.io/api/news?id=9b4dc5f84549fc23cc11e827e82d6faa97d78cdf14ce8f97fa48caaeb3957450",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie is raising its outlook with Skyrizi and Rinvoq offsetting Humira losses. Pfizer is rebuilding its pipeline around obesity drugs and key readouts expected over the next year.",
                "category": "company",
                "datetime": 1792074965,
                "headline": "AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142883028,
                "url": "https://finnhub.io/api/news?id=75721135bb49e54013e4edce260011d449765a0799cb0783d4aa98bcf70e1f71",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Level AI, the customer intelligence platform for contact centers, today announced that Shane Abeyratne, Senior Vice President, Global Business & Finance Services at Cardinal Health, has joined the company's CX Advisory Board.",
                "category": "company",
                "datetime": 1791982860,
                "headline": "Level AI's CX Advisory Board adds Shane Abeyratne, SVP at Cardinal Health"
              },
              {
                "id": 142887609,
                "url": "https://finnhub.io/api/news?id=6c04e31187b8dc420ff637db89c029ce287fdfa4fd998f8f9fd3af02aac7a89c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health is set to report its Q1 results next month, with analysts expecting double-digit year-over-year EPS growth.",
                "category": "company",
                "datetime": 1791979954,
                "headline": "What to Expect From Cardinal Health’s Q1 2027 Earnings Report"
              },
              {
                "id": 142882290,
                "url": "https://finnhub.io/api/news?id=dad524e982dd6c58bdb1fa3180264aef3534e3fa2d3d927ace66c7ffc4b03f05",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1791898511,
                "headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 142849044,
                "url": "https://finnhub.io/api/news?id=fff2c2687f2485f8b522e1ef8ed6f60c96be3b7e694891cac131e7792759142f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1791895205,
                "headline": "Should Value Investors Buy Cardinal Health (CAH) Stock?"
              },
              {
                "id": 142849043,
                "url": "https://finnhub.io/api/news?id=702d29a3595bb5bd6ce2b235c02198bf102a56838370cf44c3869e37f14fb1af",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1791895205,
                "headline": "Are Medical Stocks Lagging  Cardinal Health (CAH) This Year?"
              },
              {
                "id": 142825453,
                "url": "https://finnhub.io/api/news?id=5c26291ca92708763cb3875dc9ab591493dcebb54023a277eefc0cab5d20c7fa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie trades at a 40% valuation discount but faces revenue concentration risk, while Eli Lilly's cardiometabolic dominance commands a premium.",
                "category": "company",
                "datetime": 1791849061,
                "headline": "AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142819117,
                "url": "https://finnhub.io/api/news?id=b7d310c02badcba6b5491cdf01827cd87d65bc4f68e94038d857b7107ee5ec73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.",
                "category": "company",
                "datetime": 1791803463,
                "headline": "3 Momentum  Stocks to Target This Week"
              },
              {
                "id": 142797831,
                "url": "https://finnhub.io/api/news?id=9216952c4c5e90fa2b3d1e936ea6ee1b87f485b130df536bba452535a29d7a4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health (CVS) is expanding its pharmacy-focused format by opening nearly 20 smaller neighborhood locations across the US in 2026, including a new Roxbury site in the Boston area. Recent headlines around CVS Health have mixed signals for investors, with Medicare Advantage star rating setbacks and a legal probe weighing on sentiment, while the extended Cardinal Health distribution deal and a reaffirmed dividend provide a steadier backdrop. Even after a one-day share price decline of 1.87%...",
                "category": "company",
                "datetime": 1791684620,
                "headline": "CVS Health (CVS) Opens New Pharmacy Sites As Undervalued Narrative Holds"
              },
              {
                "id": 142774378,
                "url": "https://finnhub.io/api/news?id=6ecf61a08d4e89e309d2bc77c13f5e7c620f7c06baba3507c179f7718a35d78e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Get a weekly dividend recap for Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend dates and pay dates.",
                "category": "company",
                "datetime": 1791584761,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week October 11"
              },
              {
                "id": 142723435,
                "url": "https://finnhub.io/api/news?id=08bacb4f6c36d927c4722aa7437f7f46dee36fd9755b9cab015cc8d26f7cf7dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health (NYSE:CVS) has extended its long-term pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032. The renewed contracts keep CVS Health as a major customer for both wholesalers, supporting its nationwide pharmacy and retail operations. Management highlighted that the agreements cover prescription drug distribution across CVS Health's retail pharmacies and other dispensing channels. The extension of CVS Health's Cardinal Health and McKesson distribution...",
                "category": "company",
                "datetime": 1791454308,
                "headline": "What Does CVS Health (CVS) Gain From Extending Its Drug Distribution Deals To 2032?"
              },
              {
                "id": 142665841,
                "url": "https://finnhub.io/api/news?id=7684ab149c75a6611241a6e241b1447bfb4abc3df76fac2245282768a6c23163",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.",
                "category": "company",
                "datetime": 1791294240,
                "headline": "Reasons to Retain Cardinal Health Stock in Your Portfolio for Now"
              },
              {
                "id": 142662955,
                "url": "https://finnhub.io/api/news?id=a79264aca14b600f8fd73874c113158161ffe44d0b27110d763f44af3d82f8bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Eli Lilly's revenue surged 44.7% in 2025, but Novo Nordisk trades at less than a quarter of its valuation multiple, a stark contrast that reshapes the risk-reward calculus.",
                "category": "company",
                "datetime": 1791293401,
                "headline": "Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142662991,
                "url": "https://finnhub.io/api/news?id=c2cebee0fa6630ea0ee5e9b180005fb1bd4bc8037ddffd67aeb2c4c0ba81dafa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health raises its Health Care Benefits outlook as stronger core trends, led by Medicare, support margin recovery despite medical cost pressures.",
                "category": "company",
                "datetime": 1791289980,
                "headline": "CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?"
              },
              {
                "id": 142663311,
                "url": "https://finnhub.io/api/news?id=350be1c6b590d42583c8170b02cb9c8b72ab948cea820cf13c0bc283ebf7f1d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 40.7% over the past six months, topping the S&P 500 by 23.9 percentage points.",
                "category": "company",
                "datetime": 1791288514,
                "headline": "1 Healthcare Stock with Exciting Potential and 2 We Find Risky"
              },
              {
                "id": 142639890,
                "url": "https://finnhub.io/api/news?id=2a9b5c4bc94a40076ace620f6e0412366dce644e40182ad35f6f69dfcf6878f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.",
                "category": "company",
                "datetime": 1791234004,
                "headline": "Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know"
              },
              {
                "id": 142807153,
                "url": "https://finnhub.io/api/news?id=e92046e308d4620c73845da54ed92b68656e124fbed6946590a065983126f8a2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 117 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Up",
                "category": "company",
                "datetime": 1791219564,
                "headline": "Dollar Tree Upgraded, Kroger Downgraded: Updated Rankings on Top Blue-Chip Stocks"
              },
              {
                "id": 142636803,
                "url": "https://finnhub.io/api/news?id=dffa9ba00a4611b8858f901f1a866fd56d06d2beaa5eeb4456000feed06ec675",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Delray Beach, FL , Oct. 05, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global disposable medical devices market to grow from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, at a CAGR of 4.9% during the forecast period. Market growth is driven by the increasing emphasis on infection prevention and cross-contamination control, rising prevalence of chronic diseases, an aging population, growing surgical volumes, and expanding demand for long-term care, outpatient services, a",
                "category": "company",
                "datetime": 1791210600,
                "headline": "Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™"
              },
              {
                "id": 142628856,
                "url": "https://finnhub.io/api/news?id=e3ffb0f1fe5ae01f9083e2e296562d1a5501b5f31ced31fd008934d7ec94bd70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In October 2026, Cardinal Health announced it had entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, maintaining the current scope of distribution services. This long‑dated extension reinforces the durability of Cardinal Health’s core distribution relationships, underscoring the importance of scale partnerships in its business model. We’ll now explore how the extended CVS distribution agreement through 2032 may...",
                "category": "company",
                "datetime": 1791174359,
                "headline": "How Extending CVS Distribution Through 2032 At Cardinal Health (CAH) Has Changed Its Investment Story"
              },
              {
                "id": 142624185,
                "url": "https://finnhub.io/api/news?id=773d3787e684fba498bba3b49094c209329c0e46fcca5973e7c495eb6d0c1b89",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "One offers a more affordable entry point while the other boasts some of the highest profit margins in the sector. The choice comes down to whether you prioritize income stability or growth potential.",
                "category": "company",
                "datetime": 1791124497,
                "headline": "Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142590125,
                "url": "https://finnhub.io/api/news?id=aab9006d36a58b02b2253317f1a39f0abf20a3409f003a8d9a70e4e807671336",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "CAH",
                "summary": "Stay tuned for the market movements in the S&P500 index on Friday. Check out the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1790951701,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 142588574,
                "url": "https://finnhub.io/api/news?id=84ccaec2825b0d28abb6caaf6d3fe52e576a7aa1808c568dab8b141291eaad47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Medical-dental supplies see durable demand from specialty care, AI and aging trends, with McKesson and peers navigating tariffs and inflation.",
                "category": "company",
                "datetime": 1790944860,
                "headline": "Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex"
              },
              {
                "id": 142563714,
                "url": "https://finnhub.io/api/news?id=e98e6cb8cdda4ddef333d043a63b0f58a5549656408252b35331ef9926a27d67",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie boasts stronger revenue growth and free cash flow, while Bristol Myers Squibb trades at half the valuation with nearly double the profit margin.",
                "category": "company",
                "datetime": 1790894462,
                "headline": "AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142562967,
                "url": "https://finnhub.io/api/news?id=9d7bff0be52d529ad903a77d56eecb8aaef835962d84ed7e21814020cb92bdec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Investing.com -- Cardinal Health Inc (NYSE:CAH) shares rose 3.7% in Thursday trading after the company announced an extension of its drug distribution agreement with CVS Health through June 2032.",
                "category": "company",
                "datetime": 1790885537,
                "headline": "Cardinal Health rises on extended CVS distribution deal"
              },
              {
                "id": 142557871,
                "url": "https://finnhub.io/api/news?id=ca08e87cc073b3537b6302b1aec358a9cd9a40e9b1c53e2b993d3d4418c781d1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The extended agreement will maintain the existing scope of distribution services provided by Cardinal Health to CVS Health.",
                "category": "company",
                "datetime": 1790858503,
                "headline": "Cardinal Health Extends CVS Health Pharmaceutical Distribution Agreement Through 2032"
              },
              {
                "id": 142588192,
                "url": "https://finnhub.io/api/news?id=a5de3a7978cd533cf49a7a5e0e5decbfe12ed24021ec5e06c8d8665b7e74714a",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/01/Chandler--Arizona---April-08-2023cvs-Hea.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.",
                "category": "company",
                "datetime": 1790855987,
                "headline": "Cardinal Health, McKesson Double Down on CVS Deals Through 2032"
              },
              {
                "id": 142557889,
                "url": "https://finnhub.io/api/news?id=6aef2f6be077d7cadc16d7f461abb00cb9e3ac60b722a6e258a13f9e2397edee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.",
                "category": "company",
                "datetime": 1790855760,
                "headline": "5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve"
              },
              {
                "id": 142555641,
                "url": "https://finnhub.io/api/news?id=a3e1502d871bcbe56680cad5d7fbab78b10d436546c0ffb25a9b10b239fbb40d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services.",
                "category": "company",
                "datetime": 1790851800,
                "headline": "Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health"
              },
              {
                "id": 142555642,
                "url": "https://finnhub.io/api/news?id=83e78399d70d2e9048bbc59653dbbd066a665595ec345dded4fcdfc971e16be8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2027 on November 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.",
                "category": "company",
                "datetime": 1790851500,
                "headline": "Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5"
              },
              {
                "id": 142557331,
                "url": "https://finnhub.io/api/news?id=181eabde1818c936b30e2f64f1c7596b6288dec66316bdc0bdd85fcb15ddede9",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) reaffirmed FY2027 Adj EPS of $12.40-$12.60 vs $12.04 analyst estimate.",
                "category": "company",
                "datetime": 1790839562,
                "headline": "Cardinal Health Affirms FY2027 Adj EPS Of $12.40-$12.60 vs $12.04 Est"
              },
              {
                "id": 142557332,
                "url": "https://finnhub.io/api/news?id=da931cbb6650fcaea5d4f69e876f89483afdf8236ea63bf3931ad705f7175288",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal",
                "category": "company",
                "datetime": 1790838000,
                "headline": "Cardinal Health Enters Into Binding LOI To Extend Existing Distribution Agreement With CVS Health Through June 30, 2032"
              },
              {
                "id": 142522612,
                "url": "https://finnhub.io/api/news?id=39c8b0d65d016661fc240daa4dc5d5c622c60cf374cedbb1865d36d02d4b09f9",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2233434722/image_2233434722.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health remains a Buy, driven by robust FY2026 results, strong cash flow, and credible FY2027 guidance. Read more on CAH stock here.",
                "category": "company",
                "datetime": 1790780492,
                "headline": "Cardinal Health: I'm Still Buying After Checking The Numbers"
              },
              {
                "id": 142499515,
                "url": "https://finnhub.io/api/news?id=ace080066fe00e3cab647d5a3270d58d32b923e43edeab3791ffd85545748769",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Even though Cardinal Health (currently trading at $220.37 per share) has gained 6.8% over the last six months, it has lagged the S&P 500’s 22.1% return during that period. This may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1790699042,
                "headline": "Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 7,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.3,
            "source_article_count": 50,
            "discarded_article_count": 43
          },
          "sentimentPoints": 3
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 21,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1.5,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日3日)；站上MA50；升放量(近10日3日)；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 1878226.6666666667,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1839120,
              "avg_vol_20": 1700470,
              "avg_vol_30": 1878226.6666666667,
              "range_pct_10": 0.10069965415837065,
              "range_pct_20": 0.16899893333064067,
              "range_pct_30": 0.16899893333064067,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9791789418387556,
              "dist_to_20d_high": 0.029589908938309113,
              "down_shrink_days": 3,
              "breakout_level_20d": 259.20999,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.5958597026251946
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.2393655974940607,
              "turnoverUsdM": 422.50442654329,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.CAH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 240.2742,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.5,
            "take_profit_price": 264.7398,
            "target_multiplier": 1.9,
            "technical_strength": 1.85,
            "take_profit_percent": 5.2
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.4787311949881214,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 5.6329,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.24
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "適中偏強",
      "score": 8,
      "value": 67.45
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1572
    },
    "kdj": {
      "d": 82.72,
      "j": 53.35,
      "k": 72.93,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 60.92
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": -3864829,
      "recentSlope": 42187.1,
      "previousSlope": 297990
    },
    "rsi": 71.44,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 247.1855,
      "position": "SAR喺價下",
      "distancePct": 1.73,
      "previousTrend": "上升"
    },
    "ma50": 236.5984,
    "macd": {
      "macd": 6.1273304939985564,
      "trend": "強烈看漲",
      "signal": 5.008601465285123,
      "histogram": 1.1187290287134335
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 242.8005,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 16
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.01,
      "score": 6,
      "avgVolume": 1664809,
      "currentVolume": 1679671
    },
    "derived": {
      "ma20": 241.8885,
      "ma50": 236.5984,
      "prevClose": 249.57,
      "avgVolume10": 1883627,
      "avgVolume20": 1664809,
      "changePercent": 0.79,
      "avgVolumeForScore": 1664809
    },
    "ma_cross": {
      "ma20": 241.8885,
      "ma50": 236.5984,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 240.326,
      "prevMa50": 236.271,
      "spreadPct": 2.24,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 219.176,
      "upper": 264.601,
      "position": "上半部"
    },
    "rsi_short": 42.25,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.01
    }
  }
}

{
  "close": 251.54,
  "volume": 1679671,
  "changePercent": 0.79
}